Search

everythinglearnresearchcommunity

for

Search:↓

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Spironolactone may help reduce hair growth and testosterone levels in some women with hirsutism.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

Melatonin protects skin against UV damage by regulating various cellular processes.

Androgens like testosterone increase colon muscle contractions by affecting calcium pathways.

Both birth control pills improved hormone levels and skin conditions in women with hyperandrogenism, but the one with drospirenone was more effective.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

Young women with high male hormone levels or PCOS often feel more psychological distress and have a lower quality of life.

South Asian women with PCOS present with different symptoms compared to White women, influenced by ethnicity, obesity, and age.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Fibroblasts help understand androgen resistance at the cellular level.

Combination therapy significantly reduces testosterone and moderately reduces hair growth in women with hirsutism.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Women with PCOS have unhealthy changes in their cholesterol particles that are not related to their body weight.

The document concludes that diagnosing and treating Congenital Adrenal Hyperplasia is complex and requires a team approach due to its effects on the skin and other symptoms.

The document concludes that more multidisciplinary research is needed to understand and treat PCOS, a condition that significantly affects women's health and quality of life.

Oestrogen does not affect adrenal androgen levels in children and adolescents.

Using 17-hydroxyprogesterone levels to diagnose nonclassic congenital adrenal hyperplasia can result in many incorrect diagnoses.

Researchers found an RNA transcript that might help control a growth factor linked to tumor development.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

Most patients experienced hirsutism again after stopping hormone treatment, indicating long-term treatment is needed to maintain results.

Obese and non-obese women with PCOS have higher heart risk markers, especially if they are obese.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

NFIB and STAT5 work together to control specific genetic programs in cells.

Spironolactone may help reduce hair loss in androgenic alopecia.

Women with PCOS often have more sleep problems than the general population.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.